Correlative studies further identified conserved human CIC::DUX4 transcriptional targets including ETV1, ETV4, and CCND2. The authors subsequently leveraged this mouse model to test treatment strategies and noted tumor growth inhibition using genetic and pharmacologic approaches that block the CCND2-CDK4/6 complex. This evidence concerns the gene DUX4 and neoplasm.